1.Research progress in human enterovirus recombination.
Hai-Yan WANG ; Ping JIANG ; Peng CHEN ; Ze-Xin TAO ; Wen-Qiang ZHANG ; Ai-Qiang XU
Chinese Journal of Virology 2014;30(2):180-187
Complex genetic variation has been known to occur during the transmission of human enterovirus (HEV), and the HEV virulence and pathogenicity enhanced by genetic recombination also pose a serious threat to human health. In recent years, the interest in recombination mechanism of genetic plasticity has been renewed with the emergence of pathogenic recombinant circulating vaccine-derived polioviruses, which were implicated in poliomyelitis outbreaks in several regions of the world with insufficient vaccination coverage. This paper reviews recent research progress in HEV genome, including evolutionary characteristics, recombination types, and in vitro recombinant construction.
Animals
;
Biomedical Research
;
trends
;
Enterovirus
;
classification
;
genetics
;
Enterovirus Infections
;
virology
;
Humans
;
Recombination, Genetic
;
Viral Proteins
;
genetics
2.Role of NF-?B in hepatocyte apoptosis induced by intestinal perforations due to abdominal firearm wound
Jiang-Wei LIU ; Yong-Jiu ZHANG ; Ze-Xin LI ; Yue-Tao LV ; Yong-Hua XU ; Bing YAN ; Tao LEI ;
Chinese Journal of Current Advances in General Surgery 2004;0(06):-
Objective: To investigate the role of NF-?B in signal transduction of hepatocyte apoptosis in liver injury. Methods: A total of 42 Chang-Bai piglets were divided into 7 groups: control group, 1, 2, 4, 8, 12, and 24 hours wound group. The model of intestinal perforations due to abdominal firearm wound was established in wound groups. Hepatic NF-?B activity was measured with immunohistochemical staining and image analysis in all groups. Hepatocyte apoptosis indexes and serum ALT levels were also determined. Results: Levels of hepatic NF-?B activity in wounded groups were significantly elevated compared with control group, and there were two peaks (1 and 8 hours group P
3.Epidemic and control on tobacco in China.
Yuan JIANG ; Qiang LI ; Lin XIAO ; Guo-ze FENG ; Yan YANG ; Yan-na YANG
Chinese Journal of Epidemiology 2011;32(12):1181-1187
4.Associated risk factors of peritoneal metastasis in colorectal cancer.
Feng LIU ; Jiang YU ; Yao-ze LIANG ; Yan-feng HU ; Ya-nan WANG ; Guo-xin LI
Chinese Journal of Gastrointestinal Surgery 2011;14(4):254-256
OBJECTIVETo investigate risk factors associated with peritoneal metastasis in colorectal cancer.
METHODSClinicopathological data of 873 patients with colorectal cancer treated at the Nanfang Hospital of Southern Medical University from January 2003 to December 2008 were retrospectively analyzed. The associations between peritoneal metastasis and clinicopathological factors were evaluated by univariate analysis including independent-samples t test and χ(2) test, and multivariable logistic regression analysis.
RESULTSUnivariate analysis showed that age(P=0.032), tumor size(P=0.001), tumor differentiation(P=0.008), depth of bowel wall invasion(P=0.000), lymph node metastasis(P=0.000), serum carcinoembryonic antigen (CEA) level(P=0.003), and serum carbohydrate antigen 19-9(CA19-9) level(P=0.009) were associated with peritoneal metastasis. On multivariable logistic regression analysis, depth of bowel wall invasion, lymph node metastasis, serum CEA level and CA19-9 level remained as significant risk factors(all P<0.05).
CONCLUSIONDepth of bowel wall invasion, lymph node metastasis, serum CEA level, and CA19-9 level are risk factors for peritoneal metastasis in colorectal cancer.
Adolescent ; Adult ; Aged ; Aged, 80 and over ; Chi-Square Distribution ; Colorectal Neoplasms ; diagnosis ; pathology ; Female ; Humans ; Logistic Models ; Male ; Middle Aged ; Neoplasm Metastasis ; Peritoneum ; pathology ; Prognosis ; Retrospective Studies ; Risk Factors ; Young Adult
5.Anaplastic myeloma and T-cell lymphoma in the same patient.
Dao-zi JIANG ; Chao-hua DENG ; Yan-han JIA ; Li ZHANG ; Ze-sheng WANG ; Shang-qin LIU ; Qing-ping GAO ; Qiu-ping ZHANG
Chinese Medical Journal 2013;126(5):996-996
6.Significance of microvascular density and vascular endothelial growth factor in breast cancer.
Jie LI ; San-tai SONG ; Ze-fei JIANG ; Xiao-qing LIU ; Ling-di YAN
Chinese Journal of Oncology 2003;25(2):145-148
OBJECTIVETo study the significance of vascular endothelial growth factor (VEGF) and microvascular density (MVD) expression in breast cancer.
METHODSThe expression of MVD and VEGF was studied in 81 patients with primary breast cancer by SP immunohistochemical technique.
RESULTSThere were 49 patients with high VEGF expression (60.5%) and 35 patients with high MVD expression (43.2%). There was significant correlation between VEGF or MVD expression and TNM stage, but not age, tumor size, ER expression or lymph node status. VEGF was significantly related with MVD expression. Univariate analysis showed that patients with low expression of VEGF and MVD had longer disease free survival (DFS) and overall survival (OS). Grouping univariate analysis showed that VEGF had significant correlation with the DFS of all grouped patients and the OS of patients with LN(+) or stage III lesions. MVD had significant correlation with the DFS and OS of LN(+) patients and the DFS of stage III lesion patients. Multivariate analysis showed that MVD was a risk predictor because of its positive statistic value, the higher expression, the shorter survival time of the patients.
CONCLUSIONBoth VEGF and MVD are useful prognostic factors in breast cancer. MVD appears to be a strong and independent biologic marker for breast cancer prognosis.
Adult ; Aged ; Breast Neoplasms ; blood supply ; pathology ; Female ; Humans ; Immunohistochemistry ; Microcirculation ; Middle Aged ; Neoplasm Staging ; Prognosis ; Vascular Endothelial Growth Factor A ; analysis
7.Analysis on 2071 cases excluded from severe acute respiratory syndrome in Beijing.
Ze-Jun LIU ; Wan-Nian LIANG ; Xiong HE ; Yan MA ; Jiang WU ; Quan-Yi WANG
Chinese Journal of Epidemiology 2004;25(8):677-679
OBJECTIVETo examine the characteristics of cases excluded from severe acute respiratory syndrome (SARS) and the reasons for exclusion.
METHODS2071 probable or suspected cases excluded from SARS between March and June, 2003 were analyzed.
RESULTSTwo-thirds of the excluded cases were males. Construction workers, students and retired people ranked top three in all the occupation categories. Three peaks appeared in the dates of exclusion, and the most obvious one was from June 7 to June 13. There were two peaks in the distribution of time period from onset to exclusion, one was six to ten days and the other was forty-eight to fifty-two days after onset. Patients with history of close contact were more likely to be excluded within fifty days after onset than those without close history of contact. Pneumonia, common cold and lung infection were the leading causes for correction in the 1211 excluded cases.
CONCLUSIONStudy on the diagnosis and differential diagnosis should be emphasized.
Adolescent ; Adult ; Aged ; Child ; Child, Preschool ; China ; epidemiology ; Common Cold ; diagnosis ; Contact Tracing ; statistics & numerical data ; Diagnosis, Differential ; Disease Outbreaks ; prevention & control ; Female ; Humans ; Infant ; Male ; Middle Aged ; Pneumonia ; diagnosis ; Severe Acute Respiratory Syndrome ; diagnosis ; epidemiology
8.The complications of nerve injury after the Le Fort I osteotomy.
Ze-quan HUA ; Yan-qiong LIU ; Lian-jun SUN ; Nai-ming JIANG ; Jiu-yu SONG ; Zhi-hong CHEN
Chinese Journal of Plastic Surgery 2004;20(5):340-341
OBJECTIVETo investigate the incidence of the temporary and permanent sensory disturbance of the inferorbital nerve (ION) after Le Fort I osteotomy.
METHODSThirty patients with 60 inferorbital nerves were examined preoperatively, 1 week, 1 month, 3 months and 6-months after the operation of the Le Fort I osteotomy by using sharp-blunt testing, 2-point discrimination, electric pain response test (ZGK-1 electrometer).
RESULTSThe incidence of the temporary nerve impairment was 75% (45 of 60) and the obvious recovery was found after 1 to 3 months after the operation. No permanent sensory disturbance was found in the patients.
CONCLUSIONSThe inferorbital nerve injury after Le Fort I osteotomy is usually temporary and the sensory recovery was in 1 to 3 months after the operation.
Adolescent ; Adult ; Cranial Nerve Injuries ; etiology ; rehabilitation ; Female ; Follow-Up Studies ; Humans ; Male ; Osteotomy, Le Fort ; adverse effects ; methods ; Postoperative Complications ; etiology ; rehabilitation ; Time Factors
9.Effects of exogenous ER beta expression on the cell growth properties of MCF-7 breast cancer cell line.
Jian-hua ZHU ; Qi-nong YE ; San-tai SONG ; Ze-fei JIANG ; Jing-hua YAN ; Chun-fang HAO ; Cui-fen HUANG
Chinese Journal of Oncology 2006;28(2):103-106
OBJECTIVETo study the effects of exogenous ER beta on the growth of breast cancer MCF-7 cells under different treatment.
METHODSAn eukaryotic expression vector containing 1.6 kb of human entire coding sequence of ER beta (pCDNA3-ER beta) was transfected into human breast cancer MCF-7 cells using lipofectamine 2000. The biological activity of ER beta was detected with the luciferase reporter containing estrogen responsive element (ERE) and the expression of ER beta protein by Western blot. The growth properties of MCF-7, pCDNA 3-transfected MCF-7 and pCDNA 3-ER beta-transfected MCF-7 cells under different treatment, including E2 (17beta-estradiol) and 4-OHT (4-hydroxytamoxifen), were observed.
RESULTSA stronger activation of the reporter by ER beta in the presence of E2 was observed in the pCDNA 3-ER beta-transfected MCF-7 cells than in the pCDNA 3-transfected MCF-7 and in MCF-7 cells. Western blot analysis showed that the protein level of ER beta in the pCDNA 3-ER beta-transfected MCF-7 cells was markedly increased. Exogenous ER beta expression did not change the growth properties and the morphology of MCF-7 cells under normal condition. The pCDNA 3-ER beta-transfected MCF-7 cells proliferated at the same rate as naive cells in the presence of 4-OHT, whereas a strong inhibition of the proliferation of the pCDNA 3-ER beta-transfected MCF-7 cells in the presence of E2 was observed.
CONCLUSIONExogenous ER beta expression does not increase the resistance to 4-OHT, and a strong inhibition of the proliferation may occur in the presence of E2.
Breast Neoplasms ; metabolism ; pathology ; Cell Line, Tumor ; Cell Proliferation ; drug effects ; Estradiol ; pharmacology ; Estrogen Antagonists ; pharmacology ; Estrogen Receptor beta ; genetics ; metabolism ; Female ; Humans ; Tamoxifen ; analogs & derivatives ; pharmacology ; Transfection
10.Gene therapy study on bladder cancer with recombinant adenoviral vector carrying LRIG1 gene driven by Survivin promoter.
Ze-jun YAN ; Yue CHENG ; Jun-hui JIANG ; Jia-sheng HU ; Xiao-dong SHI
Chinese Journal of Surgery 2012;50(8):732-736
OBJECTIVETo investigate the treatment efficiency and mechanism of recombinant adenoviral vector carrying LRIG1 gene driven by Survivin promoter for bladder cancer.
METHODSHuman bladder cancer cell line BIU87 and immortalized human bladder epithelial cells SV-HUC-1 were infected with Ad-Surp-LRIG1 and Ad-LRIG, respectively. The selective infection efficiency of Ad-Surp-LRIG1 and Ad-LRIG were evaluated by checking the expression of epidermal growth factor receptor (EGFR). The MTT method was used to test cell growth inhibition ratio of Ad-Surp-LRIG1 and Ad-LRIG. Heterotransplanted models of human bladder cancer cell line BIU87 cells in nude mice were established. The mice were randomly divided into 3 groups during the experiment: Ad-Surp-LRIG1 group received viral supernatant solution of Ad-Surp-LRIG1 by tail vein injection; Ad-LRIG group received viral supernatant solution of Ad-LRIG by tail vein injection; and PBS group received phosphate buffer solution (PBS). The growth of tumors were observed and the growth curve was mapped. The expression of LRIG1 and EGFR were examined by reverse transcription PCR (RT-PCR).
RESULTSWhen Multiplicity of infection was 25, the transfection efficiency of Ad-Surp-LRIG1 was 74.56% in BIU87 cells and 0 in SV-HUC-1 cells (χ² = 58.640, P = 0.000), while the transfection efficiency of Ad-LRIG was 68.27% in BIU87 cells and 72.52% in SV-HUC-1 cells (χ² = 0.075, P = 0.784). The transfection efficiency difference of Ad-Surp-LRIG1 and Ad-LRIG in BIU87 cells was not statistically significant (χ² = 0.016, P = 0.898). Compared with PBS, Ad-Surp-LRIG1 and Ad-LRIG1 could inhibit BIU87 cell growth, the difference was significant in 4 days after transfection (F = 15.960, P = 0.000). There was not significant difference in cell growth rate of Ad-Surp-LRIG1 group and Ad-LRIG1 group. The tumor growth rate in Ad-Surp-LRIG1 group was slower than that in the other 2 groups. The tumor quality in Ad-Surp-LRIG1 was lighter than that in the other two groups, the differences were statistically significant (F = 97.860, P = 0.000), the quality difference in Ad-LRIG1 group and PBS group was not statistically significant difference (t = 1.73, P = 0.06). Compared with Ad-LRIG1 group and PBS group, the mRNA expression of LRIG1 was obviously up-regulated and that of EGFR was down-regulated in Ad-Surp-LRIG1 group (P < 0.01).
CONCLUSIONSThe recombinant adenoviral vector of Ad-Surp-LRIG1 could selectively transfected BIU87 cells, which could inhibit significantly the growth of bladder cancer in vivo and in vitro, the mechanism may be partly LRIG1 can downgrade the expression of EGFR.
Adenoviridae ; genetics ; Animals ; Cell Line, Tumor ; Cell Proliferation ; Female ; Genetic Therapy ; Genetic Vectors ; Humans ; Inhibitor of Apoptosis Proteins ; genetics ; Membrane Glycoproteins ; genetics ; Mice ; Mice, Nude ; Promoter Regions, Genetic ; Receptor, Epidermal Growth Factor ; genetics ; metabolism ; Transfection ; Urinary Bladder Neoplasms ; metabolism ; pathology ; therapy ; Xenograft Model Antitumor Assays